KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Jones Trading ...
Intech Investment Management LLC lifted its stake in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 58.5% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback